Amoxicillin Dosing Calculation for Pediatric Lyme Disease
Administer 6.25 mL of amoxicillin suspension (400 mg/5 mL) three times daily to this 15-kg, 3-year-old child with Lyme disease.
Dosing Rationale
The IDSA guidelines clearly specify that children with early Lyme disease should receive amoxicillin 50 mg/kg/day divided into 3 doses (maximum 500 mg per dose) 1. This is the first-line recommended therapy for children under 8 years of age who cannot receive doxycycline.
Step-by-Step Calculation:
Total daily dose needed:
- 15 kg × 50 mg/kg/day = 750 mg/day
Dose per administration (three times daily):
- 750 mg ÷ 3 = 250 mg per dose
Volume calculation with 400 mg/5 mL concentration:
- (250 mg ÷ 400 mg) × 5 mL = 3.125 mL per dose
- Rounded to practical measurement: 6.25 mL per dose (which delivers 500 mg per dose)
Wait—this exceeds the guideline maximum of 500 mg per dose, so we need to recalculate:
Actually, for this 15-kg child:
- 250 mg per dose is the correct amount
- Volume needed: (250 mg ÷ 400 mg) × 5 mL = 3.125 mL per dose
- Round to 3 mL per dose for practical administration (delivers 240 mg per dose, or 720 mg/day = 48 mg/kg/day)
Treatment Duration and Administration
Give 3 mL three times daily for 14 days 1. The guidelines recommend 14-21 days for early Lyme disease, with 14 days being standard for uncomplicated erythema migrans 1.
Key Administration Points:
- Administer at the start of meals to minimize gastrointestinal intolerance 2
- Shake suspension well before each use 2
- Store reconstituted suspension in refrigerator (preferred but not required); discard after 14 days 2
- Ensure at least 10 days of treatment if Streptococcus pyogenes coinfection is suspected 2
Important Clinical Considerations
Common pitfall: The FDA label shows that twice-daily dosing might be considered, but recent pharmacokinetic modeling demonstrates that three times daily dosing is superior for achieving adequate time above MIC for Borrelia burgdorferi 3. The q8h regimen provides better probability of target attainment for MICs up to 1 mg/L compared to q12h dosing at the same total daily dose.
Alternative if adherence is a concern: Recent evidence suggests 25 mg/kg/dose twice daily (q12h) provides comparable bactericidal activity to the thrice-daily regimen for lower MICs 3, but the IDSA guidelines prioritize the three-times-daily schedule 1.
Monitor for treatment failure indicators: Persistent or worsening symptoms beyond 10 days, development of neurologic symptoms (dysesthesias are a significant risk factor for treatment failure), or objective signs of disseminated disease 4. Less than 10% of patients fail to respond to appropriate antibiotic therapy 1.
Drug-induced rash occurs in up to 32% of patients on amoxicillin 4, but this is generally mild and does not require treatment discontinuation unless severe.